Antibody–drug conjugates and immunogenic cell death in breast cancer: agent-specific mechanisms, clinical evidence and translational priorities.

Journal: Frontiers in Immunology •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Fang L, Song J, Wang X, et al. (2026). "Antibody–drug conjugates and immunogenic cell death in breast cancer: agent-specific mechanisms, clinical evidence and translational priorities.". Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1978134